Brentwood, Tenn.-based Surgery Partners has watched its stock lose more than a third of its value since recording an all-time high of $67.05 this June. The NASDAQ listed the company's stock at $41.50 on Oct. 6.
Here are 11 things to know:
- The biggest single sale by an insider in the last year was when the chief growth officer Anthony Taparo sold $3.2 million worth of shares on May 10 at a price of $50.55 per share.
- The above sale represented 37 percent of Mr. Taparo's stake.
- The company released its second-quarter financial report Aug. 4, showing a 45 percent revenue increase year over year to $543.3 million. Net loss was $26.9 million.
- During the second quarter of 2021, total joint replacement volume grew 144 percent at Surgery Partners facilities, and one-third of those cases were for Medicare beneficiaries.
- Meadowbrook Endoscopy Center in Long Island, N.Y., joined the Surgery Partners network in August. The 20-physician group's ASC has four operating rooms.
- Surgery Partners aims to execute more than $400 million in transactions this year.
- Since September 2020, company insiders as a whole have sold more shares than they've bought. They have sold 185,998 shares worth over $9.5 million, while they have bought only 2,000 shares totaling just over $93,000.
- Since June, company insiders have sold at least 7,898 shares worth almost $500,000.
- From March to June, insiders sold 173,185 shares totaling nearly $9 million. No insider sales were made in that period.
- All shares bought by company insiders in the past year have occurred between June and October 2021.
- The company's stock performance over the last six months proportionally lags behind the parent companies of three of its main competitors: Dallas-based United Surgical Partners International; Deerfield, Ill.-based Surgical Care Affiliates; and Nashville, Tenn.-based HCA Healthcare.